Aug 28, 2015 02:41 AM EDT
A woman who recently returned to the U.S. from a trip to an Ebola-affected country has been showing signs and symptoms of the Ebola virus. The woman from the state of Ohio is under observation in the Ohio Health Grant medical in Columbus.
The woman, who has not been named, reported to the nurses at Columbus Public Health (CPH) that she is manifesting Ebola-like symptoms. Although the case has not been confirmed as she is still currently under observation.
Ebola, previously known as the Ebola hemorrhagic fever, is a severe ailment fatal to humans. It spreads through human-to-human transmission through close contact of blood and other body fluids. Infected humans are deemed non-contagious until symptoms such as vomiting, diarrhea, internal and external bleeding, and symptoms of liver and kidney functions develop. As of today, no vaccine is available, but there are two potential vaccines under trial.
Ebola outbreak started in southern Guinea on Dec 2013. Since then, it has been tussling several nations of West Africa like Liberia, Senegal, Nigeria and Sierra Leone.
The spokesperson of CPH, Jose Rodriguez, said that a day-to-day monitoring of travellers from the countries mentioned above is being done. In fact, since Nov it has monitored around 360 individuals, and today, they had 36 under observation, including the woman.
The hospital where the woman was brought set up a decontamination station as a precautionary measure to people whom the woman might have close contact with.
Based on the statistics of the Centers for Disease Control and Prevention, the disease is still raving with around 17,300 confirmed cases and about 6,500 confirmed deaths. Although in Liberia, the case is deemed under control.
1. 11:38 AM
2. 11:36 AM
1980s Style Aquariums are Taking Over Interiors
3. 11:35 AM
Next Solar Cycle Would Be at its Lowest in 2020
2. 11:29 AM
The Mass Suffering of Bald Eagles Due to Lead Poisoning
3. Jun 15, 2019
Rabies Can Be Transmitted Through a Simple Scratch
4. Jun 15, 2019
Researchers Discover Characteristics to Personalize Treatment for HPV-Related Head and Neck Cancer